Life Sciences
Technology
SaaS Finance
Sustainable + Renewable
Special Situations
Select Page
Life Sciences
Technology
SaaS Finance
Sustainable + Renewable
Special Situations
About
Meet our team
Investor Relations
Portfolio
Podcast
Careers
Giving Back
Press Releases
Contact Us
×
Presentations
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Presentations
Email Alerts
Company Info
Overview
Executive Team
Annual Reports & Proxy
Contacts
FAQ
ESG
Financial Info
Overview
Financial Results
Credit Ratings
Stock Data
Overview
Quote
Charts
Historical Data
Analyst Coverage
Distributions
Tax Information
Distributions Reinvestment Program
Insider Ownership
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Whistleblower Policy
Q2 2020
Jul 30, 2020
Investor Presentation
Q1 2020
May 4, 2020
Investor Presentation
Q4 2019
Feb 20, 2020
Investor Presentation
Q3 2019
Oct 30, 2019
Investor Presentation
Q2 2019
Aug 1, 2019
Investor Presentation
Q1 2019
May 2, 2019
Investor Presentation
Q4 2018
Feb 21, 2019
Investor Presentation
Q3 2018
Nov 1, 2018
Investor Presentation
Oct 29, 2018
Regulatory Relief and Incremental Use of Leverage and Shareholder Value Creation
Q2 2018
Aug 2, 2018
Investor Presentation
rss_feed
RSS
arrow_back
1
2
3
arrow_forward
Email Alerts
Contacts
RSS News Feed
